• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Mannkind/Afrezza and/or Technosphere up for sale!





Whoever gets Afrezza has a monopoly for at least 5 years, maybe 10.

While we are sticking syringes into spinal cords, hip, sexy social media stars are spreading the word that they have their best numbers ever. Total control, blood glucose 90-110 all day long, some even giving up their pumps.

Some use with basal (tresiba or generic), some just use for glucose spikes.

It's really good medicine. Why it was so great when Pfizer was launching their hexavalent by inhalation (which was not exactly bright), but not now when it's monovalent, totally beyond me.

If anyone has something to share here, I would love to hear it. I would LOVE to sell this.